FDAFDA · Food and drugs·Recall number D-0621-2020
EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,
Published December 11, 2019 · Recall initiated: November 21, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Sub Potent Drug: Out of Specification (OOS)
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- EXPAREL
- Manufacturer
- Pacira Pharmaceuticals, Inc.
- Distributor
- Distributed Nationwide in the USA
- Lot
- Pacira Lot #: 19-5002, Patheon manufacturer Lot #: 098214; Exp. Date: Dec 2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.